At SignatureDx, we are spearheading research in advanced diagnostics to develop novel methods for the early detection and treatment of complex human disease. Early diagnosis of complex human disease gives individuals the best chance for successful treatment. When care is delayed or inaccessible there is a lower quality of treatment, greater problems associated with treatment and higher costs of care. Early diagnosis improves patient outcomes by providing care at the earliest possible stage. SignatureDx is changing the paradigm of healthcare intervention by developing noninvasive methods to detect and monitor silently progressing complex human disease through our revolutionary bioanalytical platform.
| Website | http://signaturedx.com |
| Employees | 19 (14 on RocketReach) |
| Address | 1501 Preble Ave Suite 200, Pittsburgh, Pennsylvania 15221, US |
| Phone | +1 412-677-0664 |
| Industry | Hospitals and Health Care |
| Keywords | Innovative Diagnostics, Advanced Diagnostics, Early Disease Detection, Disease Prevention, Predictive Diagnostics, Precision Diagnostics, Diagnostic Research, Disease Biomarkers, Medical Diagnostics, Health Diagnostics, Biomedical Research, Diagnostic Testing, Molecular Diagnostics, Clinical Diagnostics, Disease Diagnostics, Healthcare Diagnostics, Diagnostic Tools |
| Competitors | Foundation Medicine, Caris Life Sciences, Guardant Health, Tempus Labs, Inc., Freenome, Invitae, Myriad Genetics, NantHealth, 23andMe Inc, GRAIL +46 more (view full list) |
Looking for a particular SignatureDx employee's phone or email?
Dave Colaizzi is the Co-Founder, CEO of SignatureDx.
14 people are employed at SignatureDx.
SignatureDx is based in Pittsburgh, Pennsylvania.